| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |